Actinium-225 Production
Various Cancers (as a therapeutic payload)
CommercialActive
Key Facts
About Niowave
Niowave is a private, industry-leading supplier of medical radioisotopes essential for targeted alpha therapies in oncology. The company leverages its proprietary superconducting electron linear accelerator technology and advanced radiochemistry to produce isotopes like Ac-225, addressing a critical supply bottleneck in the radiopharmaceutical sector. With deep technical expertise built over two decades, Niowave operates under cGMP standards and aims to enable the clinical development and commercialization of novel cancer treatments. Its integrated model of designing, building, and operating its own accelerator infrastructure provides full control over production quality and scalability.
View full company profile